๐ŸŽ Black Friday: up to 50% off of annual plans
G&E Herbal Biotechnology Co., Ltd. (TPEX:4911)
Taiwan flag Taiwan ยท Delayed Price ยท Currency is TWD
22.50
-2.50 (-10.00%)
Nov 20, 2026, 1:30 PM CST

G&E Herbal Biotechnology Financials Overview

Millions TWD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
170.13309.13249.03181.4464.6124.57
Revenue Growth
-45.43%24.13%37.25%180.84%162.94%-12.96%
Gross Profit
130.06263.22205.34144.5939.359.63
Operating Income
47.17152.3119.6580.685.49-19.56
Net Income
55.36139.2102.0672.47.38-19.88
Earnings Per Share
0.812.021.481.050.11-0.29
EPS Growth
-61.13%36.25%40.82%901.00%--

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
328.36430.31408.87312.92205.95108.88
Total Debt
2.520.871.751.98--
Net Cash (Debt)
325.83429.44407.13310.94205.95108.88
Net Cash Growth
-20.60%5.48%30.93%50.98%89.15%-9.31%
Net Cash Per Share
4.756.235.914.512.991.58

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-4.4170.18134.68113.4899.96-9.19
Capital Expenditures
-3.13-3.2-5.92-5.52-2.95-1.77
Free Cash Flow
-7.5466.98128.76107.9697.01-10.96
Free Cash Flow Growth
--47.98%19.26%11.29%--

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
76.45%85.15%82.46%79.69%60.91%39.17%
Operating Margin
27.72%49.27%48.04%44.47%8.49%-79.61%
Pretax Margin
31.88%51.24%50.08%49.88%11.19%-74.16%
Profit Margin
32.54%45.03%40.98%39.90%11.42%-80.92%
FCF Margin
-4.43%21.67%51.70%59.50%150.15%-44.61%

Dividends

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period EndingNov '26 Dec '25 Dec '24 Dec '23
Dividend Per Share
1.0801.0800.7040.461
Dividend Per Share Growth
66.38%53.43%52.65%-
Dividend Yield
4.80%2.72%1.45%0.92%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
27.8919.6432.7247.51402.69-
P/FCF Ratio
-40.8225.9431.8630.64-
PS Ratio
9.108.8413.4118.9646.0163.43